1. Home
  2. RIP
  3. View Record
https://www.nationalacademies.org/trb/events

Communicable Disease Preparedness: TRIP-X Improvements and Validation

The Office of Aerospace Medicine needs to quantitatively model disease transmission risk in commercial air travel and assess mitigations to inform public health preparedness. Preliminary work under a prior project developed two risk modeling approaches for an inter-agency Safety Risk Management (SRM) team convening in Q3FY25. One approach, advanced through a FAA partnership with international, interagency, and industry partners, built on work by the Boeing Confident Traveler Initiative, to develop the Travel Risk In Pandemics (TRIP-X) tool. Further work is required to refine the model beyond SRM needs and prepare it for broader use by the end of Q2FY26. Tasks include finalizing parameters; integrating disease testing and quarantine risk controls; model validation; improving computational efficiency and user experience; and documenting the model. This research supports the FAA’s Aviation Safety Research Strategy Public Health thrust and depends on concurrent data from National Research Council Canada and NIOSH for validation.